Navigation Links
AquaBounty Cleared To Produce Salmon Eggs In Canada For Commercial Purposes
Date:11/25/2013

MAYNARD, Mass., Nov. 25, 2013 /PRNewswire/ -- AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority owned subsidiary of Intrexon Corporation (NYSE: XON), announces that Environment Canada, the agency of the Government of Canada with responsibility for regulating environmental policies and issues, has decided that AquAdvantage® Salmon ("AAS") is not harmful to the environment or human health when produced in contained facilities.  The publication of the Significant New Activity Notice (http://gazette.gc.ca/rp-pr/p1/2013/2013-11-23/html/notice-avis-eng.html#d106) recognizes that our hatchery, which produces sterile, all-female eggs, is no longer solely a research facility but can produce eggs on a commercial scale without harm to the environment or human health.

"We are pleased to note that, after a rigorous examination of our hatchery facility and the Standard Operating Procedures used to produce AAS eggs, Environment Canada is satisfied that we can responsibly produce our sterile, all-female eggs on a commercial scale," said Ron Stotish, AquaBounty CEO. "This is a significant milestone in our efforts to make AquAdvantage® Salmon available for commercial production. However, our eggs and fish will not be available for sale until they are approved by the relevant national regulatory bodies. When these approvals are in place, we look forward to demonstrating the value of AAS for a land-based and environmentally-sustainable production system."

Environment Canada made its conclusion following a risk assessment conducted by Fisheries and Oceans Canada involving a panel of independent scientific experts knowledgeable in the fields of transgenics and fish containment technology.

The publication describes conditions that would be regarded as Significant New Activities (SNAcs) with regard to AquAdvantage® Salmon and the measures Environment Canada would expect to evaluate if those activities were proposed. AquaBounty confirms that, currently, all anticipated activities fall well within the scope of the approval given by Environment Canada.

About AquaBounty Technologies

AquaBounty Technologies is a biotechnology company focused on improving productivity in commercial aquaculture, a $100 billion industry and the fastest growing segment of the worldwide food industry. The company's objective is the application of biotechnology to ensure the availability of high quality seafood to meet global consumer demand. The company is developing products to address critical production constraints in the most popular farmed species, focusing initially on salmon, trout and tilapia.  Its AquAdvantage® fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.


'/>"/>
SOURCE Aqua Bounty Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
2. New techniques produce cleanest graphene yet
3. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
4. Researchers produce nanostructures with potential to advance energy devices
5. BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform
6. New Method to Produce Blood Cells from Stem Cells Could Yield a Purer, Safer Cell Therapy
7. New Way to Mass-produce Natural Cancer-killing Cells Offers Hope for Patients
8. Stem cells produce compact, regenerated bone in mandible transplants
9. Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale
10. Boston College researchers unique nanostructure produces novel plasmonic halos
11. SurePure Seals Deal with Major Mexican Food Producer Signifying Continued Traction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Lajollacooks4u has become a rising hotspot for specialized team building events in ... Fortune 500 companies, such as Illumina, Hewlett-Packard, Qualcomm and Elsevier, have traveled from ... Each event kicks off with an olive oil and salt-tasting competition. From there, ...
(Date:5/25/2016)... Oregon (PRWEB) , ... May 25, 2016 , ... ... Set features a variety of fracture-specific plating options designed to address fractures of ... industry-leading fracture fixation solutions. , The Acumed Ankle Plating System 3 is composed ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... issued by the Office of the National Coordinator for Health IT (ONC) outlining ... if clinically relevant data were available when and where it was needed. The ...
(Date:5/25/2016)... SALT LAKE CITY, UTAH. (PRWEB) , ... May 25, 2016 , ... ... create efficiencies in healthcare information exchange, today announced that Charles W. Stellar has been ... served as WEDI’s interim CEO since January 2016. As an executive leader with more ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):